PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ARWR vs. PODD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


ARWRPODD
YTD Return-6.21%-22.03%
1Y Return18.30%-45.65%
3Y Return (Ann)-23.11%-14.11%
5Y Return (Ann)9.40%12.24%
10Y Return (Ann)6.29%13.65%
Sharpe Ratio0.29-1.12
Daily Std Dev63.14%41.30%
Max Drawdown-99.96%-90.28%
Current Drawdown-99.02%-48.77%

Fundamentals


ARWRPODD
Market Cap$3.37B$11.49B
EPS-$2.77$2.94
PEG Ratio-1.322.95
Revenue (TTM)$181.74M$1.70B
Gross Profit (TTM)$240.74M$805.60M
EBITDA (TTM)-$285.35M$308.60M

Correlation

0.26
-1.001.00

The correlation between ARWR and PODD is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

ARWR vs. PODD - Performance Comparison

In the year-to-date period, ARWR achieves a -6.21% return, which is significantly higher than PODD's -22.03% return. Over the past 10 years, ARWR has underperformed PODD with an annualized return of 6.29%, while PODD has yielded a comparatively higher 13.65% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%200.00%400.00%600.00%800.00%1,000.00%1,200.00%OctoberNovemberDecember2024FebruaryMarch
-53.18%
960.03%
ARWR
PODD

Compare stocks, funds, or ETFs


Arrowhead Pharmaceuticals, Inc.

Insulet Corporation

Risk-Adjusted Performance

ARWR vs. PODD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Arrowhead Pharmaceuticals, Inc. (ARWR) and Insulet Corporation (PODD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ARWR
Arrowhead Pharmaceuticals, Inc.
0.28
PODD
Insulet Corporation
-1.12

ARWR vs. PODD - Sharpe Ratio Comparison

The current ARWR Sharpe Ratio is 0.28, which is higher than the PODD Sharpe Ratio of -1.12. The chart below compares the 12-month rolling Sharpe Ratio of ARWR and PODD.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50OctoberNovemberDecember2024FebruaryMarch
0.28
-1.12
ARWR
PODD

Dividends

ARWR vs. PODD - Dividend Comparison

Neither ARWR nor PODD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ARWR vs. PODD - Drawdown Comparison

The maximum ARWR drawdown since its inception was -99.96%, which is greater than PODD's maximum drawdown of -90.28%. The drawdown chart below compares losses from any high point along the way for ARWR and PODD


-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%OctoberNovemberDecember2024FebruaryMarch
-68.28%
-48.77%
ARWR
PODD

Volatility

ARWR vs. PODD - Volatility Comparison

Arrowhead Pharmaceuticals, Inc. (ARWR) has a higher volatility of 24.03% compared to Insulet Corporation (PODD) at 11.12%. This indicates that ARWR's price experiences larger fluctuations and is considered to be riskier than PODD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%35.00%40.00%OctoberNovemberDecember2024FebruaryMarch
24.03%
11.12%
ARWR
PODD